Smart insulin pump shows promise for type 2 diabetes control
NCT ID NCT05815342
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 29 times
Summary
This study tested the Omnipod 5, an automated insulin delivery system, in 343 adults with type 2 diabetes who need insulin. The goal was to see if the system safely improves blood sugar control. Participants used the device for 13 weeks, and researchers measured changes in HbA1c and time in target blood sugar range.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AccellaCare
Wilmington, North Carolina, 28401, United States
-
Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
-
Diabetes and Glandular Disease Clinic
San Antonio, Texas, 78229, United States
-
Diabetes and Thyroid Center
Fort Worth, Texas, 76132, United States
-
East Coast Institute for Research
Jacksonville, Florida, 32216, United States
-
East Coast Institute for Research
Canton, Georgia, 30114, United States
-
Emory
Atlanta, Georgia, 30303, United States
-
Endocrine Research
Roswell, Georgia, 30076, United States
-
Health Partners
Minneapolis, Minnesota, 55416, United States
-
Henry Ford
Detroit, Michigan, 48202, United States
-
Joslin Diabetes
Boston, Massachusetts, 02215, United States
-
MAHEC
Asheville, North Carolina, 28803, United States
-
Metabolic Research Institute
West Palm Beach, Florida, 33401, United States
-
Ohio State
Columbus, Ohio, 43203, United States
-
Physicians East
Greenville, North Carolina, 27834, United States
-
Sansum Diabetes Research Institute
Santa Barbara, California, 93105, United States
-
Texas Diabetes and Endocrinology
Austin, Texas, 78731, United States
-
University Diabetes and Endocrine Consultants
Chattanooga, Tennessee, 37411, United States
-
University of Colorado
Aurora, Colorado, 80045, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27514, United States
-
University of Southern California
Los Angeles, California, 90022, United States
Conditions
Explore the condition pages connected to this study.